134 related articles for article (PubMed ID: 17102119)
1. Malignant pheochromocytoma in a population-based study: survival and clinical results.
Wängberg B; Muth A; Khorram-Manesh A; Jansson S; Nilsson O; Forssell-Aronsson E; Tisell L; Ahlman H
Ann N Y Acad Sci; 2006 Aug; 1073():512-6. PubMed ID: 17102119
[TBL] [Abstract][Full Text] [Related]
2. Pheochromocytoma in children.
Ciftci AO; Tanyel FC; Senocak ME; Büyükpamukçu N
J Pediatr Surg; 2001 Mar; 36(3):447-52. PubMed ID: 11226993
[TBL] [Abstract][Full Text] [Related]
3. Treatment of bilateral pheochromocytoma and adrenal medullary hyperplasia.
Jansson S; Khorram-Manesh A; Nilsson O; Kölby L; Tisell LE; Wängberg B; Ahlman H
Ann N Y Acad Sci; 2006 Aug; 1073():429-35. PubMed ID: 17102111
[TBL] [Abstract][Full Text] [Related]
4. Clinical and pathological data of 10 malignant pheochromocytomas: long-term follow up in a single institute.
Huang KH; Chung SD; Chen SC; Chueh SC; Pu YS; Lai MK; Lin WC
Int J Urol; 2007 Mar; 14(3):181-5. PubMed ID: 17430251
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of a large series of patients surgically treated for pheochromocytoma.
Khorram-Manesh A; Ahlman H; Nilsson O; Friberg P; Odén A; Stenström G; Hansson G; Stenquist O; Wängberg B; Tisell LE; Jansson S
J Intern Med; 2005 Jul; 258(1):55-66. PubMed ID: 15953133
[TBL] [Abstract][Full Text] [Related]
6. High-dose 131I-metaiodobenzylguanidine therapy for 12 patients with malignant pheochromocytoma.
Rose B; Matthay KK; Price D; Huberty J; Klencke B; Norton JA; Fitzgerald PA
Cancer; 2003 Jul; 98(2):239-48. PubMed ID: 12872341
[TBL] [Abstract][Full Text] [Related]
7. Malignant pheochromocytoma: state of the field with future projections.
Ahlman H
Ann N Y Acad Sci; 2006 Aug; 1073():449-64. PubMed ID: 17102114
[TBL] [Abstract][Full Text] [Related]
8. [131I]metaiodobenzylguanidine treatment of malignant pheochromocytoma: experience of the Rome group.
Troncone L; Rufini V; Daidone MS; De Santis M; Luzi S
J Nucl Biol Med (1991); 1991; 35(4):295-9. PubMed ID: 1823840
[TBL] [Abstract][Full Text] [Related]
9. [131I]metaiodobenzylguanidine therapy in 20 patients with malignant pheochromocytoma.
Lumbroso J; Schlumberger M; Tenenbaum F; Aubert B; Travagli JP; Parmentier C
J Nucl Biol Med (1991); 1991; 35(4):288-91. PubMed ID: 1823838
[TBL] [Abstract][Full Text] [Related]
10. [Malignant pheochromocytoma: diagnosis and treatment].
Yang D; Li S; Li X; Liu S; Wang H; Han W; Hao J
Zhonghua Wai Ke Za Zhi; 1999 Feb; 37(2):104-5. PubMed ID: 11829794
[TBL] [Abstract][Full Text] [Related]
11. Metastases but not cardiovascular mortality reduces life expectancy following surgical resection of apparently benign pheochromocytoma.
Timmers HJ; Brouwers FM; Hermus AR; Sweep FC; Verhofstad AA; Verbeek AL; Pacak K; Lenders JW
Endocr Relat Cancer; 2008 Dec; 15(4):1127-33. PubMed ID: 18824558
[TBL] [Abstract][Full Text] [Related]
12. Mortality associated with pheochromocytoma: increased risk for additional tumors.
Khorram-Manesh A; Jansson S; Wängberg B; Nilsson O; Tisell LE; Ahlman H
Ann N Y Acad Sci; 2006 Aug; 1073():444-8. PubMed ID: 17102113
[TBL] [Abstract][Full Text] [Related]
13. Courses of malignant pheochromocytoma: implications for therapy.
Sisson JC; Shulkin BL; Esfandiari NH
Ann N Y Acad Sci; 2006 Aug; 1073():505-11. PubMed ID: 17102118
[TBL] [Abstract][Full Text] [Related]
14. Nuclear medicine therapy of pheochromocytoma and paraganglioma.
Troncone L; Rufini V
Q J Nucl Med; 1999 Dec; 43(4):344-55. PubMed ID: 10731785
[TBL] [Abstract][Full Text] [Related]
15. Experience with heart transplantation for cardiac tumors.
Goldstein DJ; Oz MC; Rose EA; Fisher P; Michler RE
J Heart Lung Transplant; 1995; 14(2):382-6. PubMed ID: 7779860
[TBL] [Abstract][Full Text] [Related]
16. Low-dose iodine-131 metaiodobenzylguanidine therapy for patients with malignant pheochromocytoma and paraganglioma: single center experience.
Shilkrut M; Bar-Deroma R; Bar-Sela G; Berniger A; Kuten A
Am J Clin Oncol; 2010 Feb; 33(1):79-82. PubMed ID: 19704370
[TBL] [Abstract][Full Text] [Related]
17. The diagnosis and management of malignant phaeochromocytoma and paraganglioma.
Chrisoulidou A; Kaltsas G; Ilias I; Grossman AB
Endocr Relat Cancer; 2007 Sep; 14(3):569-85. PubMed ID: 17914089
[TBL] [Abstract][Full Text] [Related]
18. Can quantification of VMAT and SSTR expression be helpful for planning radionuclide therapy of malignant pheochromocytomas?
Kölby L; Bernhardt P; Johanson V; Wängberg B; Muth A; Jansson S; Forssell-Aronsson E; Nilsson O; Ahlman H
Ann N Y Acad Sci; 2006 Aug; 1073():491-7. PubMed ID: 17102116
[TBL] [Abstract][Full Text] [Related]
19. [Pelvic lymphadenectomy as an alternative to adjuvant radiotherapy in early stage endometrial cancer at high risk of recurrent lymphatic metastases (stage I)].
Amato NA; Partipilo V; Mele F; Boscia F; De Marzo P
Minerva Ginecol; 2009 Feb; 61(1):1-12. PubMed ID: 19204656
[TBL] [Abstract][Full Text] [Related]
20. Sarcoma of the prostate: a single institutional review.
Janet NL; May AW; Akins RS
Am J Clin Oncol; 2009 Feb; 32(1):27-9. PubMed ID: 19194120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]